Skip to main content

Table 3 Results of 12 months aspiration therapy on quality of life, blood and urine values and HbA1c level (the latter for diabetic subjects only)

From: Aspiration therapy for obesity; a safe and effective treatment

Quality of life and biochemical data

Baseline

n = 20

12 months

n = 20

p

Quality of life

 Visual Analogue Scale*

63 (15)

83 (14)

<0.01

 EuroQoL-5D*

0.73 (0.25)

0.88 (0.13)

<0.01

Blood samples

 Potassium (mmol/l)

4.4 (4.2–4.5)

4.3 (4.0–4.5)

0.57

 Sodium (mmol/l)

140 (139–141.5)

141.5 (140–142)

0.02

 Creatinine (umol/l)

62.5 (53–67)

68 (58.5–73.5)

<0.01

Urine samples

 24 h potassium (mmol)

66 (54–87)

57 (40.5–76.5)

0.10

 24 h sodium (mmol)

203 (122–267)

147.5 (110.5–188.5)

0.02

 24 h chloride (mmol)

188 (141.5–246.5)

106 (70–143)

<0.01

 Osmolality (mmol/kg)

482 (377–681)

394 (335–571)

0.30

 pH

6.0 (5.5–6.7)

6.7 (6.2–7.0)

0.02

Subjects with diabetes mellitus

Baseline

n = 7

12 months

n = 7

p

 Blood samples

  HbA1c (mmol/mol)

47 (43–66)

42 (36–64)

0.03

  1. The five subjects who aborted treatment are excluded (presentation as per protocol at 1 year). Data are presented as median (IQR) or mean (SD), the latter indicated by *